Literature DB >> 2434431

Induction of an atypical interferon by bacteroides fragilis and Escherichia coli in experimental infections and in leukocyte cultures.

D K Blanchard, A C Rodloff, W E Steward, H Hahn, H Friedman.   

Abstract

Previous reports have shown that Bacteroides fragilis may enhance the pathogenicity of coinfecting enterobacteriaceae by interfering with the host's immune response. With the present study, we have investigated the possible role of interferons (IFN) in mediating these effects. Mice injected with B. fragilis developed moderate serum levels of IFN that appeared just prior to alterations of the animals' immunity described earlier. The IFN was neutralized by treatment with anti-IFN-alpha/beta-antibodies or hydrochloric acid; hence it displayed the same "atypical" characteristics as IFN found in patients with immuno-compromising diseases such as AIDS, systemic lupus erythematosus or rheumatoid arthritis. Escherichia coli displayed the same induction patterns as B. fragilis, while gram-positive bacteria induced "regular" IFN alpha/beta and gamma. Spleen cells, peritoneal macrophages, or liver leukocytes taken from B. fragilis or E. coli-injected animals 6 h post infection were refractory to IFN induction by E. coli lipopolysaccharide in vitro; cells from mice infected with gram-positive organisms showed normal or enhanced responsiveness.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2434431     DOI: 10.1007/bf01643965

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  25 in total

1.  Cellular basis of interferon formation and hyporeactivity after exposure to bacterial lipopolysaccharide.

Authors:  M Ho; M C Breinig; N Maehara
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

2.  Interferon appearance stimulated by endotoxin, bacteria, or viruses in mice pre-treated with Escherichia coli endotoxin or infected with Mycobacterium tuberculosis.

Authors:  J S Youngner; W R Stinebring
Journal:  Nature       Date:  1965-10-30       Impact factor: 49.962

3.  Tolerance to the induction of interferons by endotoxin and virus: role of a humoral factor.

Authors:  M Ho; Y Kono; M K Breinig
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

4.  Cellular origin of interferon induced by bacterial lipopolysaccharide.

Authors:  N Maehara; M Ho
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

5.  Influence of interferon on human monocyte to macrophage development.

Authors:  S Becker
Journal:  Cell Immunol       Date:  1984-03       Impact factor: 4.868

6.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

7.  Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages.

Authors:  H Rollag; M Degré; G Sonnenfeld
Journal:  Scand J Immunol       Date:  1984-08       Impact factor: 3.487

8.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.

Authors:  O T Preble; R J Black; R M Friedman; J H Klippel; J Vilcek
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

9.  Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood.

Authors:  L Rönnblom; A Forsgren; G V Alm
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Synergistic lethality in experimental infections with Escherichia coli and Bacteroides fragilis.

Authors:  A C Rodloff; H Hahn
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.